NB-PP_1170x120

Pfizer

GSK, Pfizer create O-T-C giant

GSK, Pfizer create O-T-C giant

NEW YORK — GlaxoSmithKline Plc and Pfizer Inc. have struck a deal that will create the largest over-the-counter drug company in the world. GSK paved the way for a split into two companies, agreeing to create the consumer-health joint venture with Pfizer. GSK, according to the deal, with retain a 68% controlling stake in the new

More specialty drugs available through AllianceRx Walgreens Prime

More specialty drugs available through AllianceRx Walgreens Prime

ORLANDO, Fla. — Patients with certain rare, chronic and complex conditions can now obtain the medications that may improve or save their lives from AllianceRx Walgreens Prime, a leading central specialty and home delivery pharmacy. The hard-to-find drugs, called limited distribution drugs, treat such rare conditions as metastatic breast cancer, chronic liver disease, metastatic non-small cell

Pfizer report looks at consumers and preventative health care measures

Pfizer report looks at consumers and preventative health care measures

PARIS —  A new report based on research by the Economist Intelligence Unit (EIU) and sponsored by Pfizer Vaccines assesses why, despite the evidence supporting the medical and cost-saving benefits of preventative health care measures, consumers regularly choose not to adopt them. Through interviews with leading international experts, the report reviews the psychological factors affecting consumer and

Pfizer to build sterile injectable plant in Michigan

Pfizer to build sterile injectable plant in Michigan

NEW YORK — Pfizer announced it will increase its commitment to U.S. manufacturing with a $465 million investment to build one of the most technically advanced sterile injectable pharmaceutical production facilities in the world in Portage, Michigan. This U.S. investment will strengthen Pfizer’s capability to produce and supply critical, life-saving injectable medicines for patients around

Pfizer to organize into three businesses for future growth

Pfizer to organize into three businesses for future growth

NEW YORK — Pfizer Inc. announced it will organize the company into three businesses: a science-based Innovative Medicines business which will now include biosimilars and a new hospital business unit for anti-infectives and sterile injectables; an off-patent branded and generic Established Medicines business operating with substantial autonomy within Pfizer and a Consumer Healthcare business. These

Pfizer biosimilar IXIFI approved by FDA

Pfizer biosimilar IXIFI approved by FDA

NEW YORK — Pfizer Inc. has received approval from the Food and Drug Administration for IXIFI (infliximab-qbtx), a biosimilar of Remicade (infliximab) from Janssen Biotech Inc. Pfizer said the FDA cleared IXIFI, a chimeric human-murine monoclonal antibody (mAb) against tumor necrosis factor, for the treatment of patients with rheumatoid arthritis, Crohn’s disease, pediatric Crohn’s disease, ulcerative

Teva, Greenstone roll out Viagra generics in U.S.

Teva, Greenstone roll out Viagra generics in U.S.

NEW YORK — The first generic versions of Viagra, Pfizer Inc.’s blockbuster drug for erectile dysfunction, were launched this week in the United States by Teva Pharmaceutical Industries Ltd. and Greenstone LLC. Israel-based Teva said it’s offering sildenafil citrate tablets in dosages of 25 mg, 50 mg and 100 mg. Greenstone, a Peapack, N.J.-based Pfizer subsidiary,

Pfizer appoints Albert Bourla to new COO post

Pfizer appoints Albert Bourla to new COO post

NEW YORK — In a fine-tuning of its executive leadership, Pfizer Inc. has named Albert Bourla as chief operating officer, a newly created position. Pfizer said Bourla, 56, currently group president of the Pfizer Innovative Health business unit, is slated to start in the COO role on Jan. 1. With the move, chairman and chief

Walgreens gets help with Rx disposal effort

DEERFIELD, Ill. — Four prominent players in the health care sector are coming together to help combat opioid abuse by increasing the availability of Walgreens medication disposal kiosks. The goal is to collect 300 tons of unwanted medications over the next two years through kiosks at about 1,500 Walgreens stores nationwide. Walgreens now has about

Pfizer mulls possible sale of consumer health unit

Pfizer mulls possible sale of consumer health unit

NEW YORK — Pfizer Inc. is assessing strategic options for its Pfizer Consumer Healthcare subsidiary, including a potential sale. The pharmaceutical giant said this week that it’s considering “a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.” However, the company noted that it may decided

Walgreens Rx disposal kiosk program adds partners

Walgreens Rx disposal kiosk program adds partners

DEERFIELD, Ill. — AmerisourceBergen, the Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics are helping Walgreens fight the national opioid epidemic by expanding the availability of safe medication disposal kiosks. The drug chain said Wednesday that the effort will bring the medication disposal units to an additional 900 Walgreens stores near military bases and

Patti LaBelle joins Pfizer pneumonia vaccine campaign

Patti LaBelle joins Pfizer pneumonia vaccine campaign

NEW YORK — Iconic soul singer Patti LaBelle has partnered with Pfizer Inc. in a campaign urging seniors to get vaccinated for pneumococcal pneumonia. Called “All About Your Boom,” the public awareness campaign aims to educate people age 65 and older about the risks of pneumococcal pneumonia and the need to stay up to date

Pfizer decides against split-up

Pfizer decides against split-up

NEW YORK — Pfizer says that it’s not going to split up. The pharmaceutical giant announced Monday that, following an extensive evaluation, its board of directors and executive leadership team decided to keep the company’s current structure and not pursue a separation of Pfizer Innovative Health and Pfizer Essential Health into their own publicly traded

Greenstone adds Nitrostat authorized generic

Greenstone adds Nitrostat authorized generic

PEAPACK, N.J. — Greenstone LLC has introduced nitroglycerin sublingual tablets, a medication for chest pain. The Pfizer subsidiary said Monday that its product is an authorized generic version of Nitrostat and comes in dosages of 0.3 mg (100 count), 0.4 mg (100 count) and 0.6 mg (100 count). It’s also available in a Convenience Pak